Jason Baum
Jason Baum publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Immunotherapy and Biomarkers, HER2/EGFR in Cancer Research and Cancer, Hypoxia, and Metabolism.
- World rank
- #1,096,399 of 7,710,434 ranked researchers
- Rank in United States
- #354,856 of 1,627,098
- Works
- 90
- Citations
- 910
- Citations per work
- 10.1
What does Jason Baum research?
Jason Baum's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4954.5%
- Medicine4954.5%
- Life Sciences2426.8%
- Everything else1718.7%
- 1Oncology37% of their works
- 2Molecular Biology15% of their works
- 3Pulmonary and Respiratory Medicine13% of their works
- 4Immunology6% of their works
- 5Cancer Research6% of their works
- 6Surgery5% of their works
Research topics
Which keywords describe Jason Baum's research?
The keywords of their largest research topics: Tumor Microenvironment, Chemotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Glycosylation, Breast Cancer, HER2 and EGFR Mutations.
- KRAS Mutations
- Fc Receptors
- Cancer
- Targeted Therapy
- Gastric Cancer
- EGFR Mutations
- Breast Cancer
- PD-1 and PD-L1
- Chemotherapy
- Tumor Microenvironment
- Immune Checkpoint Blockade
- Glycosylation
- HER2
- Endoscopic Resection
- HIF-1
- Warburg Effect
- Cetuximab
- Glycans
- Therapeutic Antibodies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Tumor Microenvironment212 topics
- Chemotherapy183 topics
- Immune Checkpoint Blockade151 topic
- PD-1 and PD-L1151 topic
- Glycosylation102 topics
- Breast Cancer71 topic
- HER271 topic
- EGFR Mutations61 topic
- Endoscopic Resection61 topic
- Gastric Cancer61 topic
- HIF-161 topic
- Targeted Therapy61 topic
- Warburg Effect61 topic
- Cancer51 topic
- Cetuximab51 topic
- Fc Receptors51 topic
- Glycans51 topic
- KRAS Mutations51 topic
- Therapeutic Antibodies51 topic
Where does Jason Baum work?
Jason Baum's main affiliation in the publication record is Merrimack Pharmaceuticals (United States), United States.
How many publications and citations does Jason Baum have?
OpenAlex counts 90 works and 910 citations for Jason Baum, an h-index of 13, ranking #1,096,399 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jason Baum. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.